Low-density lipoprotein-independent improvement of flow-mediated dilatation with atorvastatin: A meta-analysis and meta-regression of randomized controlled trials

International Journal of Cardiology

Volumn 158, Issue 2, 2012, Pages 285-289

  Takagi, Hisato ^a   Yamamoto, Hirotaka ^a   Iwata, Kotaro ^a   Goto, Shin Nosuke ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Atorvastatin; Flow mediated dilatation; Low density lipoprotein; Meta analysis; Meta regression; Randomized controlled trial

Indexed keywords

AMLODIPINE; ARGININE; ASCORBIC ACID; ATORVASTATIN; CERIVASTATIN; ESTRADIOL; FENOFIBRATE; LISINOPRIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; MEVINOLIN; PLACEBO; PRAVASTATIN; PREDNISONE; QUINAPRIL; ROSUVASTATIN; SIMVASTATIN;

ARTERY DILATATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DRUG DOSE TITRATION; FLOW MEDIATED DILATATION; HUMAN; LETTER; LOW DRUG DOSE; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84862232843     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.054     Document Type: Article

References (46)

1. Y. Inaba, J.A. Chen, and S.R. Bergmann Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis Int J Cardiovasc Imaging 26 2010 631 640
2. D.R. Witte, J. Westerink, E.J. de Koning, Y. van der Graaf, D.E. Grobbee, and M.L. Bots Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol 45 2005 1987 1993
3. M.K. Reriani, S.M. Dunlay, and B. Gupta Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials Eur J Cardiovasc Prev Rehabil 18 2011 704 716
4. S. Agewall, and A. Hernberg Atorvastatin normalizes endothelial function in healthy smokers Clin Sci (Lond) 111 2006 87 91
5. H.F. Alber, M. Frick, and A. Süssenbacher Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease Wien Med Wochenschr 157 2007 73 78
6. A.J. Bank, A.S. Kelly, and D.R. Kaiser The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction Vasc Med 11 2006 251 257
7. B.E. Bleske, J.M. Nicklas, and R.L. Bard Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level J Am Coll Cardiol 47 2006 338 341
8. F.V. van Venrooij, M.A. van de Ree, and M.L. Bots Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial Diabetes Care 25 2002 1211 1216
9. G.K. Dogra, G.F. Watts, D.C. Chan, and K. Stanton Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria Diabet Med 22 2005 239 242
10. G. Dogra, A. Irish, D. Chan, and G. Watts A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD Am J Kidney Dis 49 2007 776 785
11. K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia J Am Coll Cardiol 45 2005 1649 1653
12. E. Konduracka, D. Galicka-Latala, and G. Cieslik Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension Diabetes Obes Metab 10 2008 719 725
13. E. Magen, R. Viskoper, and J. Mishal Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control Isr Med Assoc J 6 2004 742 746
14. M.J. Mullen, D. Wright, A.E. Donald, S. Thorne, H. Thomson, and J.E. Deanfield Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study J Am Coll Cardiol 36 2000 410 416
15. K.C. Tan, W.S. Chow, S.C. Tam, V.H. Ai, C.H. Lam, and K.S. Lam Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus J Clin Endocrinol Metab 87 2002 563 568
16. E. Taneva, K. Borucki, and L. Wiens Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal Am J Cardiol 97 2006 1002 1006
17. W. Tantikosoom, B. Thinkhamrop, S. Kiatchusakul, N. Jarernsiripornkul, J. Srinakarin, and S. Ojongpian Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level J Med Assoc Thai 88 2005 399 406
18. A. Ceriello, R. Assaloni, and R. Da Ros Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients Circulation 111 2005 2518 2524
19. M. Chello, C. Goffredo, and G. Patti Effects of atorvastatin on arterial endothelial function in coronary bypass surgery Eur J Cardiothorac Surg 28 2005 805 810
20. J.J. Gómez-Doblas, M.F. Jiménez-Navarro, and J.M. García-Pinilla Effect of statin treatment begun early after acute myocardial infarction on endothelial function in patients with normal levels of cholesterol. VAATOPE Study (VAlue of ATOrvastatin in Postinfarction Endothelium) Med Clin (Barc) 126 2006 325 328
21. J.H. Bae, E. Bassenge, K.Y. Kim, Y.C. Synn, K.R. Park, and M. Schwemmer Effects of low-dose atorvastatin on vascular responses in patients undergoing percutaneous coronary intervention with stenting J Cardiovasc Pharmacol Ther 9 2004 185 192
22. S. Spring, R. Simon, and B. van der Loo High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial Thromb Haemost 99 2008 182 189
23. J.P. Higgins, J.J. Deeks Chapter 7: Selecting studies and collecting data J.P. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011 Available from www.cochrane-handbook.org
24. D. Follmann, P. Elliott, I. Suh, and J. Cutler Variance imputation for overviews of clinical trials with continuous response J Clin Epidemiol 45 1992 769 773
25. A. Abou-Raya, S. Abou-Raya, and M. Helmii Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers J Rheumatol 35 2008 1801 1808
26. K. Amudha, A.M. Choy, M.R. Mustafa, and C.C. Lang Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus Cardiovasc Ther 26 2008 253 261
27. J. Dupuis, J.C. Tardif, and J.L. Rouleau Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial) Am J Cardiol 96 2005 1207 1213
28. S.L. Brown, F.J. Raal, V.R. Panz, B.A. Stevens, and M.G. Veller High-dose atorvastatin therapy is required for significant improvement of endothelial function in heterozygous familial hypercholesterolaemic patients Cardiovasc J S Afr 15 2004 70 75
29. L.M. Crisostomo, C.A. Souza, C.M. Mendes, S.R. Coimbra, D. Favarato, and P.L. Luz Vascular and metabolic response to statin in the mildly hypertensive hypercholesterolemic elderly Clinics (Sao Paulo) 63 2008 589 594
30. P.A. Economides, A. Caselli, E. Tiani, L. Khaodhiar, E.S. Horton, and A. Veves The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes J Clin Endocrinol Metab 89 2004 740 747
31. A.M. El-Barbary, M.S. Hussein, E.M. Rageh, H.E. Hamouda, A.A. Wagih, and R.G. Ismail Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis J Rheumatol 38 2011 229 235
32. A.A. Faludi, J.M. Aldrighi, and M.C. Bertolami Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects Atherosclerosis 177 2004 89 96
33. J. Malik, V. Melenovsky, and D. Wichterle Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial - FAT) Cardiovasc Res 52 2001 290 298
34. R. Fathi, B. Haluska, L. Short, and T.H. Marwick A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention Am J Med 114 2003 445 453
35. M. Guazzi, G. Tumminello, G. Reina, M. Vicenzi, and M.D. Guazzi Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients Eur J Clin Invest 37 2007 454 462
36. M.T. Inanc, N. Kalay, and T. Heyit Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease Echocardiography 27 2010 997 1003
37. K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension Int J Cardiol 146 2011 319 325
38. M. Liu, F. Wang, Y. Wang, and R. Jin Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation Cardiovasc Drugs Ther 23 2009 369 376
39. B. Liu, H.M. Cao, and G.Y. Li Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis J Int Med Res 39 2011 2314 2322
40. J.R. Murrow, S. Sher, and S. Ali The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin J Clin Lipidol 6 2012 42 49
41. N. Raja-Khan, A.R. Kunselman, C.S. Hogeman, C.M. Stetter, L.M. Demers, and R.S. Legro Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial Fertil Steril 95 2011 1849 1852
42. R. Rawlings, A. Nohria, and P.Y. Liu Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in Caucasian men with a previous atherosclerotic event Am J Cardiol 103 2009 437 441
43. K. Sakabe, N. Fukuda, K. Wakayama, T. Nada, H. Shinohara, and Y. Tamura Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients Int J Cardiol 94 2004 111 117
44. L.A. Simons, D. Sullivan, J. Simons, and D.S. Celermajer Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia Atherosclerosis 137 1998 197 203
45. P.H. Stone, D.M. Lloyd-Jones, and S. Kinlay Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study Circulation 111 2005 1747 1755
46. M. Takeda, T. Yamashita, and M. Shinohara Plasma tetrahydrobiopterin/ dihydrobiopterin ratio: a possible marker of endothelial dysfunction Circ J 73 2009 955 962